Ameritas Investment Partners’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Ameritas Investment Partners’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-217	Closed	-$6K	–	3159
2019 Q1	$6K	Hold	217	–	–	﹤0.01%	2841
2018 Q4	$5K	Hold	217	–	–	﹤0.01%	2872
2018 Q3	$12K	Hold	217	–	–	﹤0.01%	2785
2018 Q2	$15K	Hold	217	–	–	﹤0.01%	2676
2018 Q1	$13K	Hold	217	–	–	﹤0.01%	2645
2017 Q4	$27K	Buy	217 +82	+61%	+$10.5K	﹤0.01%	2291
2017 Q3	$18K	Hold	135	–	–	﹤0.01%	2498
2017 Q2	$19K	Hold	135	–	–	﹤0.01%	2502
2017 Q1	$25K	Buy	+135	New	+$15.1K	﹤0.01%	2296

Other funds holding TTPH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Ameritas Investment Partners's TTPH Position: Q2 2019 in Review

Ameritas Investment Partners sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 217 shares — an estimated $6K sold.

Ameritas Investment Partners first reported a position in TTPH in Q1 2017 and held it in 9 quarters. The position peaked at $27K in Q4 2017. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

Ameritas Investment Partners reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Ameritas Investment Partners sold 217 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019, an estimated $6K.
Ameritas Investment Partners first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2017 and held it in 9 quarters.
Ameritas Investment Partners's Tetraphase Pharmaceuticals, Inc. position peaked at $27K in Q4 2017.
66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on Ameritas Investment Partners's 13F filing for Q2 2019, filed 14 Aug 2019.